Clinical research designs to study treatment effects for multidrug-resistant bacteria
- PMID: 31121323
- DOI: 10.1016/j.cmi.2019.05.004
Clinical research designs to study treatment effects for multidrug-resistant bacteria
Similar articles
-
[Antibiotic strategy in an infectious diseases unit].Presse Med. 2000 Jan 22;29(2):121-3. Presse Med. 2000. PMID: 10682044 French. No abstract available.
-
Choosing wisely between randomized controlled trials and observational designs in studies about interventions.J Bras Pneumol. 2016 May-Jun;42(3):165. doi: 10.1590/S1806-37562016000000152. J Bras Pneumol. 2016. PMID: 27383927 Free PMC article. No abstract available.
-
Randomized trials analyzed as observational studies.Ann Intern Med. 2013 Oct 15;159(8):560-2. doi: 10.7326/0003-4819-159-8-201310150-00709. Ann Intern Med. 2013. PMID: 24018844 Free PMC article. No abstract available.
-
[Linezolid (Zyvox)--a novel antibacterial agent for treatments of multidrug-resistant infections].Antibiot Khimioter. 2002;47(2):38-46. Antibiot Khimioter. 2002. PMID: 12087723 Review. Russian. No abstract available.
-
The Whys and Wherefores of Antibiotic Resistance.Cold Spring Harb Perspect Med. 2017 Feb 1;7(2):a025171. doi: 10.1101/cshperspect.a025171. Cold Spring Harb Perspect Med. 2017. PMID: 27793964 Free PMC article. Review.
Cited by
-
The role of combination therapy in the treatment of severe infections caused by carbapenem resistant gram-negatives: a systematic review of clinical studies.BMC Infect Dis. 2021 Jun 9;21(1):545. doi: 10.1186/s12879-021-06253-x. BMC Infect Dis. 2021. PMID: 34107899 Free PMC article.
-
Ceftolozane/Tazobactam for Resistant Drugs Pseudomonas aeruginosa Respiratory Infections: A Systematic Literature Review of the Real-World Evidence.Life (Basel). 2021 May 24;11(6):474. doi: 10.3390/life11060474. Life (Basel). 2021. PMID: 34073847 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical